Literature DB >> 27939016

Diagnosing pulmonary embolisms: the clinician's point of view.

A Carrillo Alcaraz1, A López Martínez2, F J Sotos Solano2.   

Abstract

Pulmonary thromboembolism is common and potentially severe. To ensure the correct approach to the diagnostic workup of pulmonary thromboembolism, it is essential to know the basic concepts governing the use of the different tests available. The diagnostic approach to pulmonary thromboembolism is an example of the application of the conditional probabilities of Bayes' theorem in daily practice. To interpret the available diagnostic tests correctly, it is necessary to analyze different concepts that are fundamental for decision making. Thus, it is necessary to know what the likelihood ratios, 95% confidence intervals, and decision thresholds mean. Whether to determine the D-dimer concentration or to do CT angiography or other imaging tests depends on their capacity to modify the pretest probability of having the disease to a posttest probability that is higher or lower than the thresholds for action. This review aims to clarify the diagnostic sequence of thromboembolic pulmonary disease, analyzing the main diagnostic tools (clinical examination, laboratory tests, and imaging tests), placing special emphasis on the principles that govern evidence-based medicine.
Copyright © 2016 SERAM. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Diagnostic imaging; Diagnóstico por imagen; Embolia Pulmonar; Evidence-based medicine; Medicina Basada en Evidencias; Pulmonary embolism

Mesh:

Year:  2016        PMID: 27939016     DOI: 10.1016/j.rx.2016.10.002

Source DB:  PubMed          Journal:  Radiologia        ISSN: 0033-8338


  2 in total

1.  Blue Lungs in Covid-19 Patients: A Step beyond the Diagnosis of Pulmonary Thromboembolism using MDCT with Iodine Mapping.

Authors:  Virginia Pérez Dueñas; María Allona Krauel; Emilio Agrela Rojas; Maria Teresa Ramírez Prieto; Laura Díez Izquierdo; Ulpiano López de la Guardia; Isabel Torres Sánchez
Journal:  Arch Bronconeumol       Date:  2020-08-28       Impact factor: 4.872

2.  [Blue Lungs in Covid-19 Patients: A Step beyond the Diagnosis of Pulmonary Thromboembolism using MDCT with Iodine Mapping].

Authors:  Virginia Pérez Dueñas; María Allona Krauel; Emilio Agrela Rojas; Maria Teresa Ramírez Prieto; Laura Díez Izquierdo; Ulpiano López de la Guardia; Isabel Torres Sánchez
Journal:  Arch Bronconeumol       Date:  2020-08-28       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.